scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JCHROMB.2009.06.029 |
P698 | PubMed publication ID | 19589736 |
P50 | author | Jos Beijnen | Q23771643 |
P2093 | author name string | A H Schinkel | |
J H M Schellens | |||
H Rosing | |||
S C Linn | |||
R H T Koornstra | |||
S F Teunissen | |||
P433 | issue | 24 | |
P921 | main subject | tamoxifen | Q412178 |
P304 | page(s) | 2519-2529 | |
P577 | publication date | 2009-06-26 | |
P1433 | published in | Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences | Q2422407 |
P1476 | title | Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry. | |
P478 | volume | 877 |
Q38243454 | Application of micellar liquid chromatography for the determination of antitumoral and antiretroviral drugs in plasma |
Q37811317 | Bioanalytical methods for determination of tamoxifen and its phase I metabolites: A review |
Q36109257 | CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. |
Q30668728 | Characterization of the isomeric configuration and impurities of (Z)-endoxifen by 2D NMR, high resolution LC⬜MS, and quantitative HPLC analysis |
Q42929605 | Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study |
Q38604479 | Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism. |
Q37597968 | Extraction of tamoxifen and its metabolites from formalin-fixed, paraffin-embedded tissues: an innovative quantitation method using liquid chromatography and tandem mass spectrometry |
Q58767256 | Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy |
Q64886091 | New UPLC–MS/MS assay for the determination of tamoxifen and its metabolites in human plasma, application to patients. |
Q35547180 | Study of tamoxifen urinary metabolites in rat by ultra-high-performance liquid chromatography time-of-flight mass spectrometry |
Q36976844 | Tamoxifen mimics the effects of endogenous ovarian hormones on repeated seizures induced by pentylenetetrazole in rats |
Q48584159 | The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifen |
Q45905355 | The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels. |
Q36197839 | UPLC-MS/MS method for the determination of tobacco-specific biomarker NNAL, tamoxifen and its main metabolites in rat plasma |
Search more.